|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/6886 | |
| G01N 33/574 |
| (11) | Patento numeris | 3152577 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15726957.2 |
| Europos patento paraiškos padavimo data | 2015-06-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-04-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-07-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2015/062331 |
| Data | 2015-06-03 |
| (87) | Numeris | WO 2015/185595 |
| Data | 2015-12-10 |
| (30) | Numeris | Data | Šalis |
| 201462009057 P | 2014-06-06 | US |
| (72) |
NITTA, Hiro, US
PADILLA, Mary T., US
RANGER-MOORE, James, US
DENNIS, Eslie, US
KUROZUMI, Sasagu, JP
KUROSUMI, Masafumi, JP
|
| (73) |
Ventana Medical Systems, Inc.,
1910 Innovation Park Drive, Tucson, AZ 85755,
US
|
| (54) | SIGNIFICANCE OF INTRATUMORAL HER2 HETEROGENEITY IN BREAST CANCER AND USES THEREFOR |
| SIGNIFICANCE OF INTRATUMORAL HER2 HETEROGENEITY IN BREAST CANCER AND USES THEREFOR |